HD-OPM Archive
Topics › Alcohol, smoking & vaping

Why smokers have 40-60% lower Parkinson's risk: low-dose carbon monoxide hypothesis

Louis Nervegna · Oct 03, 2026 · ♥ 10 reactions · 6 comments · original Facebook post
Alcohol, smoking & vapingBrain health & dementia
AI summary & key facts

The post explains that prospective studies show smokers have a much lower Parkinson's risk and that newer research points to very low-dose carbon monoxide rather than nicotine, possibly via HO-1 induction. He stresses there is no safe way to inhale CO and smoking is harmful, and suggests dietary strategies that trigger HO-1 instead.

You might be surprised to learn that smokers have lower risk of developing Parkinson’s disease. This is actually true. Multiple high-quality prospective studies have demonstrated an inverse association, and the effect size is large (40-60% lower risk).

It was long thought that nicotine was responsible for the protective effect. But newer research hints that it might actually be the exposure to very low doses of carbon monoxide.

Very low doses of carbon monoxide appear to be hormetic, especially in the brain. As the saying goes, “the difference between a poison and a medicine is the dose”.

————-

I know of no way to safely take in very low concentrations of carbon monoxide (CO) by inhalation, short of using very expensive medical equipment. Any method that involves combustion (such as smoking) is unsafe.

Instead of trying to inhale the gas (which bypasses safety margins and directly blocks oxygen delivery to the heart and brain), there is research that focuses on natural products and dietary strategies that naturally trigger the HO-1 enzyme. Roughly 80% to 88% of the CO in your body is produced naturally through the oxidative catabolism of heme (the breakdown of aging red blood cells) by an enzyme called heme oxygenase (HO-1).

Consuming plant-derived antioxidants and polyphenols (such as curcumin, resveratrol, or those found in Mediterranean diets) has been shown to gently stimulate the body's own heme oxygenase system. This allows the body to safely manufacture its own therapeutic, ultra-low doses of carbon monoxide exactly where it is needed at a cellular level, completely eliminating the catastrophic risks of inhalation.

#parkinsonsHD #smokingHD #carbonmonoxideHD #alphasynucleinHD #nicotineHD #hormesisHD

Research cited

While cigarette smoking is bad for health, it’s long been linked to a reduced risk for Parkinson’s. New research suggests this may be because smokers exhale higher levels of carbon monoxide, which, at low concentrations, has neuroprotective effects including reduction of the alpha-synuclein associated with Parkinson’s and induction of HO-1, an antioxidant and anti-inflammatory. Does This New Clue Explain the Smoking-Parkinson’s Mystery? (Medscape)

May be an image of text
← newer: Heart podcast on the LoDoCo2 imaging substudy of colchicine older: About 95% of acute-thrombosis heart attacks involve soft pla →